240 related articles for article (PubMed ID: 32782558)
1. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease.
Ye S; Yu C; Zhang G; Shi F; Chen Y; Yang J; Wu W; Zhou Y
Oncol Lett; 2020 Sep; 20(3):2411-2419. PubMed ID: 32782558
[TBL] [Abstract][Full Text] [Related]
2. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.
Xu Y; Chen J; Gao C; Zhu D; Xu X; Wu C; Jiang J
Oncol Lett; 2017 Dec; 14(6):6379-6386. PubMed ID: 29163678
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.
Ge J; Chen Z; Li R; Lu T; Xiao G
Cancer Cell Int; 2014; 14(1):128. PubMed ID: 25525411
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
6. Identification of MXRA5 as a novel biomarker in colorectal cancer.
Wang GH; Yao L; Xu HW; Tang WT; Fu JH; Hu XF; Cui L; Xu XM
Oncol Lett; 2013 Feb; 5(2):544-548. PubMed ID: 23420087
[TBL] [Abstract][Full Text] [Related]
7. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression.
Lomperta K; Jakubowska K; Grudzinska M; Kanczuga-Koda L; Wincewicz A; Surmacz E; Sulkowski S; Koda M
World J Gastroenterol; 2020 Jul; 26(28):4140-4150. PubMed ID: 32821075
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-552 expression in colorectal cancer and its clinicopathological significance.
Im J; Nam SK; Lee HS
J Pathol Transl Med; 2021 Mar; 55(2):125-131. PubMed ID: 33596633
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
12. Correlation between miR-21 and miR-145 and the incidence and prognosis of colorectal cancer.
Liu Q; Yang W; Luo Y; Hu S; Zhu L
J BUON; 2018; 23(1):29-35. PubMed ID: 29552756
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.
Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR
Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients.
Sanmartín-Salinas P; Toledo-Lobo MV; Noguerales-Fraguas F; Fernández-Contreras ME; Guijarro LG
J Mol Histol; 2018 Feb; 49(1):39-49. PubMed ID: 29185229
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
Wang L; Jiang CF; Li DM; Ge X; Shi ZM; Li CY; Liu X; Yin Y; Zhen L; Liu LZ; Jiang BH
Oncotarget; 2016 Jan; 7(3):2660-71. PubMed ID: 26673620
[TBL] [Abstract][Full Text] [Related]
17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
18. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer.
Wang XJ; Xia M; Bi WP
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173188
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.
Zhao J; Xu J; Zhang R
Oncol Lett; 2018 Aug; 16(2):2693-2700. PubMed ID: 30013665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
